Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors-Reference-Cited by-同舟云学术

Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors

Published:2020-10-13 Issue:1 Volume:22 Page:47-53
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Schuettfort G¹^ORCID,Boekenkamp L¹,Cabello A²^ORCID,Cotter AG³,De Leuw P⁴,Doctor J⁵,Górgolas M²,Hamzah L⁶^ORCID,Herrmann E¹,Kann G¹,Khaykin P⁷,Mallon PW³,Mena A⁸^ORCID,Del Palacio Tamarit M²,Sabin CA⁹^ORCID,Stephan C¹,Wolf T¹^ORCID,Haberl AE¹

Affiliation:

1. HIVCENTER Department of Infectious Diseases University Hospital Frankfurt Frankfurt Germany

2. Infectious Diseases Outpatient Clinic Hospital Fundación Jiménez DíazUniversity Autónoma of Madrid Madrid Spain

3. Department of Infectious Diseases HIV Molecular Research Group University College Dublin (UCD) School of Medicine Mater Misericordae University Hospital Dublin Ireland

4. Infektiologikum Frankfurt Frankfurt Germany

5. Guy's and St Thomas' NHS Foundation Trust London UK

6. St George's Hospital NHS Foundation Trust London UK

7. MainFacharzt Frankfurt Frankfurt Germany

8. Department of Infectious Diseases A Coruña University Hospital A Coruña Spain

9. University College London London UK

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy